Cargando…

Corporate immunity to the COVID-19 pandemic

We evaluate the connection between corporate characteristics and the reaction of stock returns to COVID-19 cases using data on more than 6,700 firms across 61 economies. The pandemic-induced drop in stock returns was milder among firms with stronger pre-2020 finances (more cash and undrawn credit, l...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Wenzhi, Levine, Ross, Lin, Chen, Xie, Wensi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457922/
https://www.ncbi.nlm.nih.gov/pubmed/34580557
http://dx.doi.org/10.1016/j.jfineco.2021.03.005
_version_ 1784571209393897472
author Ding, Wenzhi
Levine, Ross
Lin, Chen
Xie, Wensi
author_facet Ding, Wenzhi
Levine, Ross
Lin, Chen
Xie, Wensi
author_sort Ding, Wenzhi
collection PubMed
description We evaluate the connection between corporate characteristics and the reaction of stock returns to COVID-19 cases using data on more than 6,700 firms across 61 economies. The pandemic-induced drop in stock returns was milder among firms with stronger pre-2020 finances (more cash and undrawn credit, less total and short-term debt, and larger profits), less exposure to COVID-19 through global supply chains and customer locations, more corporate social responsibility activities, and less entrenched executives. Furthermore, the stock returns of firms controlled by families (especially through direct holdings and with non-family managers), large corporations, and governments performed better, and those with greater ownership by hedge funds and other asset management companies performed worse. Stock markets positively price small amounts of managerial ownership but negatively price high levels of managerial ownership during the pandemic.
format Online
Article
Text
id pubmed-8457922
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84579222021-09-23 Corporate immunity to the COVID-19 pandemic Ding, Wenzhi Levine, Ross Lin, Chen Xie, Wensi J financ econ Article We evaluate the connection between corporate characteristics and the reaction of stock returns to COVID-19 cases using data on more than 6,700 firms across 61 economies. The pandemic-induced drop in stock returns was milder among firms with stronger pre-2020 finances (more cash and undrawn credit, less total and short-term debt, and larger profits), less exposure to COVID-19 through global supply chains and customer locations, more corporate social responsibility activities, and less entrenched executives. Furthermore, the stock returns of firms controlled by families (especially through direct holdings and with non-family managers), large corporations, and governments performed better, and those with greater ownership by hedge funds and other asset management companies performed worse. Stock markets positively price small amounts of managerial ownership but negatively price high levels of managerial ownership during the pandemic. Elsevier B.V. 2021-08 2021-03-07 /pmc/articles/PMC8457922/ /pubmed/34580557 http://dx.doi.org/10.1016/j.jfineco.2021.03.005 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ding, Wenzhi
Levine, Ross
Lin, Chen
Xie, Wensi
Corporate immunity to the COVID-19 pandemic
title Corporate immunity to the COVID-19 pandemic
title_full Corporate immunity to the COVID-19 pandemic
title_fullStr Corporate immunity to the COVID-19 pandemic
title_full_unstemmed Corporate immunity to the COVID-19 pandemic
title_short Corporate immunity to the COVID-19 pandemic
title_sort corporate immunity to the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457922/
https://www.ncbi.nlm.nih.gov/pubmed/34580557
http://dx.doi.org/10.1016/j.jfineco.2021.03.005
work_keys_str_mv AT dingwenzhi corporateimmunitytothecovid19pandemic
AT levineross corporateimmunitytothecovid19pandemic
AT linchen corporateimmunitytothecovid19pandemic
AT xiewensi corporateimmunitytothecovid19pandemic